BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23999140)

  • 21. Synthesis and antiviral activity of some new bis-1,3-thiazole derivatives.
    Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH
    Eur J Med Chem; 2015 Sep; 102():266-76. PubMed ID: 26291036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.
    Egorova A; Kazakova E; Jahn B; Ekins S; Makarov V; Schmidtke M
    Eur J Med Chem; 2020 Feb; 188():112007. PubMed ID: 31881489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Characterization, and Biological Evaluation of Some Novel Quinoxaline Derivatives as Antiviral Agents.
    El-Zahabi HSA
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28407276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups.
    Li X; Liu Y; Zhang YK; Plattner JJ; Baker SJ; Bu W; Liu L; Zhou Y; Ding CZ; Zhang S; Kazmierski WM; Hamatake R; Duan M; Wright LL; Smith GK; Jarvest RL; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Wang A
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7351-6. PubMed ID: 23142614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antiviral activity of cyclopropyl-spirocarbocyclic adenosine, (4R,5S,6R,7R)-4-(6-amino-9H-purin-9-yl)-7-(hydroxymethyl)spiro[2.4]heptane-5,6-diol against hepatitis C virus.
    Gadthula S; Rawal RK; Sharon A; Wu D; Korba B; Chu CK
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3982-5. PubMed ID: 21621997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.
    Gao LM; Tang S; Wang YX; Gao RM; Zhang X; Peng ZG; Li JR; Jiang JD; Li YH; Song DQ
    ChemMedChem; 2013 Sep; 8(9):1545-53. PubMed ID: 23881611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity.
    Lasheen DS; Ismail MA; Abou El Ella DA; Ismail NS; Eid S; Vleck S; Glenn JS; Watts AG; Abouzid KA
    Bioorg Med Chem; 2013 May; 21(10):2742-55. PubMed ID: 23583031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugation of cyclodextrin with fullerene as a new class of HCV entry inhibitors.
    Xiao SL; Wang Q; Yu F; Peng YY; Yang M; Sollogoub M; Sinaÿ P; Zhang YM; Zhang LH; Zhou DM
    Bioorg Med Chem; 2012 Sep; 20(18):5616-22. PubMed ID: 22884577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.
    Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD
    J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
    Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
    J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors.
    Hwang JY; Kim HY; Jo S; Park E; Choi J; Kong S; Park DS; Heo JM; Lee JS; Ko Y; Choi I; Cechetto J; Kim J; Lee J; No Z; Windisch MP
    Eur J Med Chem; 2013; 70():315-25. PubMed ID: 24177358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
    Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
    Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
    Oh CH; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel cycloalkylthiophene-imine derivatives bearing benzothiazole scaffold: synthesis, characterization and antiviral activity evaluation.
    Ke S; Wei Y; Yang Z; Wang K; Liang Y; Shi L
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5131-4. PubMed ID: 23920438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells.
    Shan GZ; Peng ZG; Li YH; Li D; Li YP; Meng S; Gao LY; Jiang JD; Li ZR
    J Antibiot (Tokyo); 2011 Feb; 64(2):177-82. PubMed ID: 21179047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fused heterocyclic amido compounds as anti-hepatitis C virus agents.
    Aoyama H; Sugita K; Nakamura M; Aoyama A; Salim MT; Okamoto M; Baba M; Hashimoto Y
    Bioorg Med Chem; 2011 Apr; 19(8):2675-87. PubMed ID: 21458278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand design, synthesis and biological anti-HCV evaluations for genotypes 1b and 4a of certain 4-(3- & 4-[3-(3,5-dibromo-4-hydroxyphenyl)-propylamino]phenyl) butyric acids and 3-(3,5-dibromo-4-hydroxyphenyl)-propylamino-acetamidobenzoic acid esters.
    Ismail MA; Abouzid KA; Mohamed NS; Dokla EM
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1274-90. PubMed ID: 23294107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives.
    Chang CS; Lin YT; Shih SR; Lee CC; Lee YC; Tai CL; Tseng SN; Chern JH
    J Med Chem; 2005 May; 48(10):3522-35. PubMed ID: 15887961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: Synthesis and biological evaluation.
    Zhang H; Zheng X; Li J; Liu Q; Huang XX; Ding H; Suzuki R; Muramatsu M; Song SJ
    Eur J Med Chem; 2021 Jun; 218():113395. PubMed ID: 33838584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.